Sign Up Today and Learn More About Hemab Stock
Invest in or calculate the value of your shares in Hemab or other pre-IPO companies through EquityZen's platform.
Hemab Stock
Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.
About Hemab Stock
Founded
2017
Industries
Hemab Press Mentions
Stay in the know about the latest news on Hemab
22 techbio soonicorns ready to cross the $1bn threshold
sifted • May 23, 2024
Methods of treating blood disorders with vwf-targeted monospecific antibodies
patents • Apr 15, 2024
Hemab Therapeutics Presents Positive Phase 1 Results for HMB-001 in Glanzmann Thrombasthenia at 2024 EAHAD ...
prnewswire • Apr 10, 2024
Hemab Therapeutics Announces First Patient Dosed in Phase ...
prnewswire • Jan 27, 2024
Biotech 2.0
sifted • Jan 27, 2024
Hemab Management
Leadership team at Hemab
Board Member
Dan Becker
CTO & Co-Founder
Johan H. Faber
Join now and verify your accreditation status to gain access to:
- Hemab current valuation
- Hemab stock price
- Available deals in Hemab and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Hemab stock?
Accredited investors can buy pre-IPO stock in companies like Hemab through EquityZen funds. These investments are made available by existing Hemab shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Hemab stock?
Shareholders can sell their Hemab stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 41K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
